Cytokine regulation of facilitated glucose transport in human articular chondrocytes

被引:120
作者
Shikhman, AR
Brinson, DC
Valbracht, J
Lotz, MK
机构
[1] Scripps Res Inst, Div Arthrit Res, MEM 161, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Div Rheumatol, La Jolla, CA 92037 USA
关键词
D O I
10.4049/jimmunol.167.12.7001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Glucose serves as the major energy substrate and the main precursor for the synthesis of glycosaminoglycans in chondrocytes. Facilitated glucose transport represents the first rate-limiting step in glucose metabolism. This study examines molecular regulation of facilitated glucose transport in normal human articular chondrocytes by proinflammatory cytokines. IL-1 beta and TNF-alpha, and to a lesser degree IL-6, accelerate facilitated glucose transport as measured by [H-3]2-deoxyglucose uptake. IL-1 beta induces an increased expression of glucose transporter (GLUT) 1 mRNA and protein, and GLUT9 mRNA. GLUT3 and GLUT8 mRNA are constitutively expressed in chondrocytes and are not regulated by IL-1 beta. GLUT2 and GLUT4 mRNA are not detected in chondrocytes. IL-1 beta stimulates GLUT1 protein glycosylation and plasma membrane incorporation. IL-1 beta regulation of glucose transport in chondrocytes depends on protein kinase C and p38 signal transduction pathways, and does not require phosphoinositide 3-kinase, extracellular signal-related kinase, or c-Jun N-terminal kinase activation. IL-1 beta -accelerated glucose transport in chondrocytes is not mediated by endogenous NO or eicosanoids. These results demonstrate that stimulation of glucose transport represents a component of the chondrocyte response to IL-1 beta. Two classes of GLUTs are identified in chondrocytes, constitutively expressed GLUT3 and GLUT8, and the inducible GLUT1 and GLUT9.
引用
收藏
页码:7001 / 7008
页数:8
相关论文
共 75 条
[1]  
ASANO T, 1991, J BIOL CHEM, V266, P24632
[2]   THE ROLE OF N-GLYCOSYLATION IN THE TARGETING AND STABILITY OF GLUT1 GLUCOSE-TRANSPORTER [J].
ASANO, T ;
TAKATA, K ;
KATAGIRI, H ;
ISHIHARA, H ;
INUKAI, K ;
ANAI, M ;
HIRANO, H ;
YAZAKI, Y ;
OKA, Y .
FEBS LETTERS, 1993, 324 (03) :258-261
[3]   Insulin signal transduction through protein kinase cascades [J].
Avruch, J .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 182 (1-2) :31-48
[4]  
BALON TW, 1995, AM J PHYSIOL, V269, pE709
[5]   Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-λ on insulin-stimulated glucose transport in L6 myotubes [J].
Bandyopadhyay, G ;
Kanoh, Y ;
Sajan, MP ;
Standaert, ML ;
Farese, RV .
ENDOCRINOLOGY, 2000, 141 (11) :4120-4127
[6]   Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells [J].
Barros, LF ;
Young, M ;
Saklatvala, J ;
Baldwin, SA .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 504 (03) :517-525
[7]   Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase [J].
Bedard, S ;
Marcotte, B ;
Marette, A .
BIOCHEMICAL JOURNAL, 1997, 325 :487-493
[8]   The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase [J].
Beltman, J ;
McCormick, F ;
Cook, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) :27018-27024
[9]  
BIRD TA, 1990, J BIOL CHEM, V265, P13578
[10]   IL-1-INDUCED NITRIC-OXIDE INHIBITS CHONDROCYTE PROLIFERATION VIA PGE2 [J].
BLANCO, FJ ;
LOTZ, M .
EXPERIMENTAL CELL RESEARCH, 1995, 218 (01) :319-325